Not contesting that the effect on NF-kB is important. I'm saying that this is not enough to provide a scientifically acceptable Mode of Action (MOA). A beginning of establishing that was shown by Dr. Mullan in his discussion of anatabine as a "cholinergic agonist." See the presentation lined on Star's site, starting at about 6:45 minutes.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.